Related Experiment Video
Updated: Jul 11, 2026
09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
The lipid storage diseases: new concepts and control
Annals of Internal Medicine
|February 1, 1975
Summary
Understanding enzymatic defects in lipid metabolism disorders enables sensitive diagnostic tests and carrier detection. Enzyme replacement therapy shows promise for conditions like Fabry
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Ten inherited disorders of lipid metabolism have well-established enzymatic defects.
- Lipid accumulation in the central nervous system poses treatment challenges.
Purpose of the Study:
- To review the diagnostic and therapeutic advancements in inherited lipid metabolism disorders.
- To highlight the potential of enzyme replacement therapy and identify areas for future research.
Main Methods:
- Utilized established knowledge of enzymatic defects in lipid metabolism.
- Reviewed recent investigations into enzyme replacement therapy.
- Examined diagnostic test development using leukocytes and fibroblasts.
Main Results:
- Facile and sensitive diagnostic tests are available for ten inherited lipid metabolism disorders.
- Tests allow for diagnosis, carrier detection, and monitoring of at-risk pregnancies.
- Enzyme replacement therapy shows promise for Fabry's disease and adult Gaucher's disease.
Conclusions:
- Diagnostic capabilities for inherited lipid metabolism disorders are robust.
- Enzyme replacement therapy is a promising treatment avenue for specific conditions.
- Further research is needed for effective enzyme replacement in CNS-affected patients.
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:25Lipid Catabolism
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...